Literature DB >> 17355661

Myth: Atropine should be administered before succinylcholine for neonatal and pediatric intubation.

Bethany Fleming1, Maureen McCollough, Henderson O Henderson.   

Abstract

Succinylcholine is often used to facilitate neonatal and pediatric rapid sequence intubation in the emergency department, and most relevant literature recommends administering atropine prior to succinylcholine to reduce the risk of bradycardia. Given the potential complications associated with combining these medications, we searched the published literature for evidence supporting this practice. Most studies recommending atropine premedication were undertaken in the operating room setting and pertained to repeated succinylcholine dosing. Furthermore, there is little published evidence to indicate that succinylcholine-related bradycardia is a clinically important side effect. Several authors have called for the practice to cease, but, to date, these calls have gone unheeded. We found no evidence supporting atropine's use in pediatric patients prior to single-dose succinylcholine. Atropine premedication for emergency department rapid sequence intubation is unnecessary and should not be viewed as a "standard of care."

Entities:  

Year:  2005        PMID: 17355661     DOI: 10.1017/s1481803500013075

Source DB:  PubMed          Journal:  CJEM        ISSN: 1481-8035            Impact factor:   2.410


  2 in total

1.  Singapore Paediatric Resuscitation Guidelines 2016.

Authors:  Gene Yong Kwang Ong; Irene Lai Yeen Chan; Agnes Suah Bwee Ng; Su Yah Chew; Yee Hui Mok; Yoke Hwee Chan; Jacqueline Soo May Ong; Sashikumar Ganapathy; Kee Chong Ng
Journal:  Singapore Med J       Date:  2017-07       Impact factor: 1.858

2.  Anticholinergic premedication-induced fever in paediatric ambulatory ketamine anaesthesia.

Authors:  Kyung Woo Kim; Won Joo Choe; Jun Hyun Kim; Kyung-Tae Kim; Sang-Il Lee; Jang Su Park; Jung Won Kim; Min Hee Heo
Journal:  J Int Med Res       Date:  2016-05-25       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.